Podcasts about diffuse

Merriam-Webster's Word of the Day for July 1, 2025 is: verbose • ver-BOHSS • adjective Someone described as verbose tends to use many words to convey their point. Verbose can also describe something, such as a speech, that contains more words than necessary. // The article documenting their meeting presented an odd exchange between a verbose questioner and a laconic interviewee. See the entry > Examples: "The dense, verbose text—over which some actors stumbled, understandably, on opening night—created a dizzying journey through a war between gods and mortals fought across time and place." — Rosa Cartagena, The Philadelphia Daily News, 19 Feb. 2025 Did you know? There's no shortage of words to describe wordiness in English. Diffuse, long-winded, prolix, redundant, windy, repetitive, rambling, and circumlocutory are some that come to mind. Want to express the opposite idea? Try succinct, concise, brief, short, summary, terse, compact, or compendious. Verbose, which falls solidly into the first camp of words, comes from the Latin adjective verbōsus, from verbum, meaning "word." Other descendants of verbum include verb, adverb, proverb, verbal, and verbicide ("the deliberate distortion of the sense of a word").

“No! I don't want to!” How many times have dads heard something like this? Is it defiance, or something else? Kids talking back is part of growing up. Dads need to know how to react when their children get mouthy. In this episode of the All Pro Dad Podcast, host Ted Lowe is joined by BJ Foster and Bobby Lewis to talk about keeping our cool when this happens in our homes.Why This MattersThere are different kinds of “talking back,” and handling them all the same could lead to friction in your relationship with your kids. Key TakeawaysTalking back, or being “mouthy,” is developmentally normal. Recognize that there are always reasons kids talk back. Practical Tools for DadsWhen your kids get mouthy, try these techniques to better understand their behavior:1. Stay calm. 2. Acknowledge their feelings. 3. Treat them with respect. 4. Remind them of the parent/child dynamic5. Focus on the message. Important Episode Timestamps00:00 – 00:55 | Introduction & Big Question of the Week00:55 – 03:13 | Personal Stories: Were You a Mouthy Kid?03:13 – 05:10 | Why Back Talk Pushes Our Buttons05:10 – 07:07 | Defiant vs. Dismissive: What Kind of Back Talk Is It?07:07 – 09:50 | Reacting vs. Responding: Fear-Based Parenting Doesn't Last09:50 – 13:36 | The Power of Curiosity: What's Really Going On?13:36 – 15:15 | The Role of Imitation in Behavior15:15 – 17:58 | Practical Tools to Diffuse the Moment17:58 – 22:00 | Teach, Don't Just Stop the Behavior22:00 – 28:00 | Pro Move of the Week:  Remember, mouthy kids are normal kids. They just need guidance. Sponsor:The All Pro Dad Podcast is proudly brought to you by Family First, a nonprofit dedicated to equipping parents with resources to strengthen their families. Learn more at FamilyFirst.net.We love feedback, but can't reply without your email address. Message us your thoughts and contact info!Connect with Us: Ted Lowe on LinkedIn Bobby Lewis on LinkedIn BJ Foster on LinkedIn Subscribe on Apple Podcasts Get All Pro Dad merch! EXTRAS: Follow us: Instagram | Facebook | X (Twitter)Join 200,000+ other dads by subscribing to the All Pro Dad Play of the Day. Get daily fatherhood ideas, insight, and inspiration straight to your inbox.This episode's blog can also be viewed here on AllProDad.com. Like the All Pro Dad gear and mugs? Get your own in the All Pro Dad store.Get great content for moms at iMOM.com

World War II bombs were defused in Cologne, Germany, which has inspired us to explore the science of diffusion and defusing!First, we hear how new, artificially intelligent video generators are modelled on diffusion. We also hear about the health impacts of home aroma diffusers and candles. We're joined by conflict-mediator Gabrielle Rifkind of the Oxford Process, to discuss the psychological stakes behind defusing conflict in wars and at home.We also taste-test the difference between raw and cooked broccoli, learn about in-insect synthesis, and explore an anechoic chamber. All that, plus many more Unexpected Elements. Presenter: Caroline Steel, with Tristan Ahtone and Edd Gent Producer: Imaan Moin, with Alice Lipscombe-Southwell, Minnie Harrop and Debbie Kilbride

Which patients with IDH-mutant glioma should receive an isocitrate dehydrogenase (IDH) inhibitor? A top neurosurgeon weighs in. Credit available for this activity expires: 6/9/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002598?ecd=bdc_podcast_libsyn_mscpedu

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?  Avec : Muriel Valin, Epsiloon : cartographie des fonds marins Mathieu Nowak, Sciences et Avenir : intestins, comprendre et combattre les maux de ventre David Fossé, Ciel & Espace : le succès historique de Camille Flammarion avec son «Astronomie populaire». François Lassagne, Pour la Science : autisme, un héritage de Néandertal ?  Thomas Delozier Science&Vie : requin blanc, ce que le monde doit aux superprédateurs Benoît Tonson, The Conversation : L'empathie n'est pas le propre de l'humain : ces singes utilisent des signaux vocaux pour se réconforterMusiques Diffusées pendant l'émission :- Big Thief - Shark smile- Tekemat, Mariaa Siga, Guiz - Comme il Est [Playlist RFI]- Miira - Où vont les larmes [Playlist RFI]- Volodia, Davojah - Regarde le ciel.

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?  Avec : Muriel Valin, Epsiloon : cartographie des fonds marins Mathieu Nowak, Sciences et Avenir : intestins, comprendre et combattre les maux de ventre David Fossé, Ciel & Espace : le succès historique de Camille Flammarion avec son «Astronomie populaire». François Lassagne, Pour la Science : autisme, un héritage de Néandertal ?  Thomas Delozier Science&Vie : requin blanc, ce que le monde doit aux superprédateurs Benoît Tonson, The Conversation : L'empathie n'est pas le propre de l'humain : ces singes utilisent des signaux vocaux pour se réconforterMusiques Diffusées pendant l'émission :- Big Thief - Shark smile- Tekemat, Mariaa Siga, Guiz - Comme il Est [Playlist RFI]- Miira - Où vont les larmes [Playlist RFI]- Volodia, Davojah - Regarde le ciel.

Des astronomes slovaques viennent de calculer l'impact sur les observatoires astronomiques de la lumière diffusée par les minuscules débris spatiaux en orbite basse dont la quantité est en croissance exponentielle du fait du déploiement des mégaconstellations de satellites. L'étude est publiée dans Monthly Notices of the Royal Astronomical Society Letters. Source Low Earth Orbit satellite fragmentation rates are critically disrupting the natural night sky backgroundM Kocifaj et al.Monthly Notices of the Royal Astronomical Society: Letters, Volume 541, (22 may 2025)https://doi.org/10.1093/mnrasl/slaf052 Illustration Carte en coordonnées polaires de la luminosité diffuse en 2035 pour les observatoires Vera Rubin (haut) et ZTF (bas). Les valeurs sont données pour le haut de l'atmosphère (gauche) et au sol (droite).

In this week's episode we'll learn about how frequent blood donation affects clonal hematopoiesis in older, male blood donors; the effect of immune microenvironment on response to bispecific antibodies in diffuse large B-cell lymphoma; and the feasibility of adding blinatumomab to early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma.Featured ArticlesClonal Hematopoiesis Landscape in Frequent Blood DonorsIntegrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseUpfront Blinatumomab Improves MRD Clearance and Outcome in Adult Ph-negative B-lineage ALL: The GIMEMA LAL2317 Phase 2 Study

Dabei handelt es sich um eine ernstzunehmende chronische Erkrankung, die das Leben vieler Betroffener stark beeinträchtigen kann. Im Durchschnitt vergehen unglaubliche sieben Jahre, bis eine Endometriose-Diagnose gestellt wird. Diese lange Zeit der Ungewissheit ist für viele Frauen eine enorme Belastung – körperlich wie emotional.

Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025.   More Information

- Overview of Diffuse Large B-Cell Lymphoma - Staging & Grading - Current Standard of Care - Treatment Options for Resistant Disease - New & Emerging Treatment Approaches - The Role of Clinical Trials - How Research Contributes to Treatment Choices - Tips to Manage Treatment Side Effects, Symptoms, Discomfort & Pain - The Increasing Role of Telehealth/Telemedicine Appointments - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions to Ask Our Panel of Experts

- Overview of Diffuse Large B-Cell Lymphoma - Staging & Grading - Current Standard of Care - Treatment Options for Resistant Disease - New & Emerging Treatment Approaches - The Role of Clinical Trials - How Research Contributes to Treatment Choices - Tips to Manage Treatment Side Effects, Symptoms, Discomfort & Pain - The Increasing Role of Telehealth/Telemedicine Appointments - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions to Ask Our Panel of Experts

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec : Muriel Valin, Epsiloon : l'IA fait revivre les génies  Arnaud Devillars, Sciences et Avenir : IA contre IA ou comment traquer les «deepfakes» ? David Fossé, Ciel & Espace : matière noire François Lassagne, Pour la Science : matière noire, les impasses, les nouvelles pistes... Dylan Beiner, Science&Vie : quantique enfin en direct. Musiques Diffusées pendant l'émission :- La Femme - Waiting in the Dark- Imagination - Just An Illusion- MLCD - The tragic tale of a genius- Moliy, Silent Addy, Skillibeng, Shenseea - Shake It To The Max (FLY) [Remix] [Playlist RFI]- Camille, Matthieu Saglio - Ginkgo Biloba [Playlist RFI]

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec : Muriel Valin, Epsiloon : l'IA fait revivre les génies  Arnaud Devillars, Sciences et Avenir : IA contre IA ou comment traquer les «deepfakes» ? David Fossé, Ciel & Espace : matière noire François Lassagne, Pour la Science : matière noire, les impasses, les nouvelles pistes... Dylan Beiner, Science&Vie : quantique enfin en direct. Musiques Diffusées pendant l'émission :- La Femme - Waiting in the Dark- Imagination - Just An Illusion- MLCD - The tragic tale of a genius- Moliy, Silent Addy, Skillibeng, Shenseea - Shake It To The Max (FLY) [Remix] [Playlist RFI]- Camille, Matthieu Saglio - Ginkgo Biloba [Playlist RFI]

Dr. Nimish Mohile and Dr. Jaishri Blakeley share the new rapid recommendation update to the therapy for diffuse astrocytic and oligodendroglial tumors in adults guideline. They review the evidence from the INDIGO trial that prompted this update, and how to incorporate the use of vorasidenib into clinical practice. They discuss the importance of molecular testing, particularly for IDH1 or IDH2 mutations and outstanding questions for treatment of patients with oligodendrogliomas and astrocytomas. Read the latest update, “Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.” Transcript This guideline, clinical tools, and resources are available at http://www.asco.org/neurooncology-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in Journal of Clinical Oncology.   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts.   My name is Brittany Harvey and today I'm interviewing Dr. Jaishri Blakeley from Johns Hopkins University School of Medicine and Dr. Nimish Mohile from the Department of Neurology and Wilmot Cancer Institute at the University of Rochester Medical Center, co-chairs on “Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: American Society of Clinical Oncology-Society for Neuro-Oncology Guideline Rapid Recommendation Update.”  Thank you for being here today, Dr. Blakeley and Dr. Mohile.  Dr. Jaishri Blakeley: Thank you.  Dr. Nimish Mohile: Thank you for having us.  Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Blakeley and Dr. Mohile who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes.   So then, to jump into the content here, Dr. Mohile, could you start us off by describing what prompted this rapid update to the ASCO-SNO therapy for diffuse astrocytic and oligodendroglial tumors in adults guideline, which was previously published in 2021?  Dr. Nimish Mohile: Yeah. So the key reason for this update is the publication of a study in 2023. And this was a study called the INDIGO study that looked at a new class of therapies, something called IDH inhibitors. And in this study with a drug called vorasidenib, changed how we think about the treatment of oligodendrogliomas and astrocytomas, so particularly the grade 2 oligodendrogliomas and grade 2 astrocytomas. Because of the results of that study, we decided that we needed to do an update to inform clinicians about some of these changes and how we might approach these tumors differently today.  Brittany Harvey: Great. I appreciate that background. So then, based off the new data from the INDIGO study, what are the updated and new recommendations from the expert panel?  Dr. Nimish Mohile: So the key findings from the INDIGO study involved people who had grade 2 astrocytomas and grade 2 oligodendrogliomas. And in the setting after surgery, they were treated with vorasidenib, and what they found is that this delayed the time to next intervention. And the key aspect of that is that it delayed when we could start radiation and chemotherapy in these patients.   So what we did in the guidelines is that for both low grade oligodendrogliomas and low grade astrocytomas, we added one additional guideline statement. Our previous guideline in 2021 offered the options for observation or treatment with radiation and chemotherapy. And now in this guideline, we have options for observation, treatment with vorasidenib in those in whom we feel it is safe to defer radiation and chemotherapy, and then treatment with radiation and chemotherapy. So we've added in an additional option here. And the key message of the guideline is really on how, as clinicians, we think about using the vorasidenib and what the ideal setting for using the vorasidenib is.  Brittany Harvey: Excellent. It's great to hear about this new option for patients. So then you were just talking about how we think about who to offer this IDH inhibitor to. So, Dr. Blakeley, what should clinicians know as they implement these new recommendations into practice?  Dr. Jaishri Blakeley: Yes. So, first and foremost, let's go back to 2021, and a key note from those guidelines was the importance of molecular testing. And at that point, the importance of molecular testing, which in large part was focused on IDH1 or IDH2 mutations, was prognostic. We could say there's a difference in an IDH1 mutant astrocytoma and an IDH1 wild type astrocytoma, but we didn't have a specific therapeutic recommendation attached to that, like Dr. Mohile just said. And the big shift here is now we have a specific therapeutic for that population with IDH1 or IDH2 mutant glioma.   So for clinicians, we hope that they've been getting molecular testing on newly diagnosed glioma already, but now there's an additional motivation to do so because it may change your treatment plan in the right circumstance. So since the publication of the phase III INDIGO study that Dr. Mohile mentioned, and the FDA approval of vorasidenib, if you meet the specified criteria in the clinical trial - which the guidelines point out is a little different than what's on the FDA label, so clinicians might want to dig into that a little bit - then there is a treatment option that is new and different than combined chemoradiation or radiation alone or observation.  Brittany Harvey: I appreciate those clarifications there.   So then also, Dr. Blakeley, how does this update impact patients with astrocytic or oligodendroglial tumors?  Dr. Jaishri Blakeley: So first, patients also should know if they have IDH mutant gliomas. And this update only applies to people with IDH1/2 mutant glioma. Perhaps, we're not sure, it might only apply to people who are in the newly or newly-ish diagnosed category because the INDIGO study required that people were within the first five years of their surgical diagnosis and had not had other treatment. So there are a lot of people who have astrocytoma or oligodendroglioma who may or may not know their IDH1/2 status and may have already had another therapy - this update doesn't apply to them. We hope that future research will teach us about that. This update is for people who are newly diagnosed and just starting the journey to figure out the best therapy. It does say that if you do have that IDH1/2 alteration in your tumor, there is a drug therapy that is different from the drug therapies we would offer gliomas that do not have the IDH1/2 mutation.  Brittany Harvey: Absolutely. I think both that emphasis on molecular testing is very important and also thinking about that study inclusion criteria and how it impacts who's eligible for this treatment.   So then finally, Dr. Mohile, what are the outstanding questions about vorasidenib or other interventions for gliomas in adults?  Dr. Nimish Mohile: I think the key question for clinicians is exactly who we're going to use this in. The challenges with inclusion criteria in clinical trials is they don't actually always match what we're seeing in the clinic. And I think it brings up the question of, in low grade oligodendrogliomas which we think of as very slow growing tumors, do we have the option outside of the strict inclusion criteria to use that drug in other settings? I think it brings up the question for some clinicians in some of the higher grade tumors, in the grade 3 tumors, we don't yet have data in that area and our guideline doesn't address that. But I think some will be asking what the clinical activity of vorasidenib is in that setting. There are some suggestions that the IDH inhibitors may impact seizure control, and I think that that's data that we're continuing to wait on.   So I think that there's several outstanding questions there that we will have answers for hopefully in the next several years. I think the big question that we don't have an answer for and that will take a long time to know is whether the addition of vorasidenib in this setting actually improves how long people live. And given how long people with low grade oligodendrogliomas and low grade astrocytomas live today, we probably won't have an answer to that question for more than a decade.  Brittany Harvey: Definitely. We'll look forward to these ongoing developments and eventually longer term data on overall survival on these agents.   So, I want to thank you both so much for your work to rapidly include this information from this new trial. And thank you for your time today, Dr. Blakeley and Dr. Mohile.  Dr. Jaishri Blakeley: Thank you so much.  Dr. Nimish Mohile: Thank you Brittany.  Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/neurooncology-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.    The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. 

In this week's episode we'll learn about the role of interleukin-1 signaling in the bone marrow microenvironment in the development of myelodysplastic syndromes, the immune checkpoint regulator VISTA as a potential target for preventing graft-vs-host disease, and epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.Featured Articles:IL-1R1 and IL-18 signals regulate mesenchymal stromal cells in an aged murine model of myelodysplastic syndromesTargeting cell-surface VISTA expression on allospecific naïve T cells promotes toleranceEpcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec : Emilie Rauscher, Epsiloon : Il était une fois la vache  Franck Daninos , Sciences et Avenir : Objectif Mars, les défis d'un vol habité David Fossé, Ciel & Espace : hors-série sur les découvreurs de l'Univers Benoit Tonson, The Conversation : Les bonobos font des phrases (presque) comme nous Thomas Delozier, Science&Vie : Editer l'ADN avant la naissanceMusiques Diffusées pendant l'émission : Thomas Fersen – Un coup de queue de vache Dumis9ne, Stepart, 16 Bazz – Intuition (avec 16 Bazz) Jimi Tenor – Is There Love In Outer Space DjeuhDjoah, Lieutenant Nicholson – Danse Divine

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec : Emilie Rauscher, Epsiloon : Il était une fois la vache  Franck Daninos , Sciences et Avenir : Objectif Mars, les défis d'un vol habité David Fossé, Ciel & Espace : hors-série sur les découvreurs de l'Univers Benoit Tonson, The Conversation : Les bonobos font des phrases (presque) comme nous Thomas Delozier, Science&Vie : Editer l'ADN avant la naissanceMusiques Diffusées pendant l'émission : Thomas Fersen – Un coup de queue de vache Dumis9ne, Stepart, 16 Bazz – Intuition (avec 16 Bazz) Jimi Tenor – Is There Love In Outer Space DjeuhDjoah, Lieutenant Nicholson – Danse Divine

What a treat to have Dr. Tabatha Barber, author of the best-selling book Fast To Faith, on the podcast. She explained that our bodies function like a chemistry experiment. When we think in a certain way, we produce chemicals that can have positive or negative effects. I don't know about you, but I do find it shocking that the thoughts I think can create chemical messengers in my body that can heal me or harm me. You have so much more power than you realize! We also discussed a topic near and dear to my heart, JOY. Where's your joy? If we put everyone else first, that will steal your happiness. Dr. T. explained that we get caught up in the lie that taking care of ourselves is selfish. She said that she felt God tell her that caring for herself wasn't selfish but SELF PRESERVATION. Dr. Tabatha shared simple tips that can help you to change your mindset and increase your daily joy. Please enjoy part one of this conversation and join us next week when we talk about 20-minute or less dinners, fasting, and her lifelong battle with depression. ______ Young Living Here's the link to my favorite essential oil kit from Young Living! The kit is called Make A Shift, and here are some suggestions on how to use these oils, along with tips on using your new essential oil diffuser (diffuser is also included!) Use the code SHAREYL for 10% off of your first order Put a few drops of Purification essential oil blend on cotton balls and place them in air vents to eliminate odors. Diffuser Lavender essential oil to create a restful environment before bed. Dilute Peppermint essential oil and rub it on your chest for a refreshing breathing experience. Roll Deep Relief Roll-On onto muscles and joints after a workout. Glide Stress Away Roll-On onto your temples for a moment of calm after a challenging day. Diffuse 8–10 drops of essential oils in the FreshStart Diffuser to freshen the air and set the scene for work, play, or rest. Click here to purchase: https://www.youngliving.com/us/en/product/make-a-shift-essential-solutions-kit?enrollerId=4557460&sponsorId=4557460 ______ Air Dr. I've been using the Air Doctor air purifier for almost a year and absolutely love it! I first heard about it from Dr. Mark Hyman, and even though it was a bit of a splurge compared to what I usually spend, I'm so glad I invested. Every time I change the filter and see all the gunk it collects, I smile, knowing it's doing a great job keeping my air clean! And I'm so happy that all that gunk isn't going into my body ;) Click here to purchase: https://airdoctorpro.com/?oid=17&affid=6165 ______ About Dr. Tabitha Barber Dr. Tabatha Barber is a doctor, author, speaker, and devoted Jesus-lover, as well as a proud mom and grandma. Overcoming the challenges of being a high school dropout and teenage mother, she became a triple board-certified physician in obstetrics and gynecology, menopause, and functional medicine. Through her medical practice, podcast, Fast to Faith supplement line, coaching academy, and international best-selling book, Fast to Faith, she empowers women to take charge of their health by addressing gut health, hormone balance, mindset, and spiritual well-being. Connect With Dr. Tabitha Barber Website: https://drtabatha.com/ Instagram: https://www.instagram.com/gutsydrtabatha/# Facebook: https://www.facebook.com/DrTabatha ______ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter!  -https://whydidigetcancer.us14.list-manage.com/subscribe?u=1c37affeccf004c8957941069&id=a8572db3c2

In this episode, Dr E and Dr Wells discuss a case of acute low back pain from a fall. That part was easy! With further discussion, the patient also reported chronic leg pain that has been progressively worsening. It was diffuse, felt in bilateral lower legs, and accompanied by unexplained bruising.Untold Physio Stories is sponsored by⁠Comprehend PT⁠- Leave Comprehend PT running in the background or record audio when you have time. The AI based SOAP note generator does the rest! No need for accuracy or exact wording! It's a game changer and will give you more time with your patients! Use code MMT50 to save 50% off your first month. Free trial available at sign up!⁠⁠The Eclectic Approach Network⁠⁠ - Check out Dr. E's all new private, non tracking and ad free network for rehab pros! It's free to join, has chat, feed, and all the features of other social networks without the creeping tracking.Check out ⁠⁠EDGE Mobility System⁠⁠'s Best Sellers - Something for every PT, OT, DC, MT, ATC or Fitness Minded Individual https://edgemobilitysystem.com

In this episode of Mind Shift, Aaron and Erwin McManus reflect on their time in Mexico City, where the Mosaic community has grown from 60 to 225 attendees in a small art gallery space. They celebrate the resilience and teamwork of the community, highlighting how adversity has strengthened their bond. This theme of overcoming conflict and fostering unity extends into a broader discussion on leadership, negotiation, and personal growth.Erwin shares key insights into conflict resolution, emphasizing the importance of diffusing crises without escalating them. He explains how power should not be fought with power, advocating instead for humility and adaptability in leadership. Drawing from his experiences in South Dallas working with drug cartels, he illustrates the value of seeing the world from another person's perspective and finding solutions that benefit all parties involved.The conversation delves into different approaches to leadership, with Aaron and Erwin comparing their psychological assessments and how their personalities shape the way they navigate conflicts. Erwin underscores the necessity of self-awareness and emotional control, warning against letting ego drive decision-making. He shares his rules for conflict resolution—never be the bomb, avoid responding to conflict with aggression, and step away if you cannot present the best version of yourself.The discussion expands to leadership on a global scale, using the Trump-Zelensky interaction as an example of how conflicts could be better managed through strategic humility and gratitude. Erwin explains how simple acts of appreciation can de-escalate tension and shift the dynamic of a conversation. He stresses the importance of intention in leadership, urging leaders to focus on their motivations rather than striving for perfection.As the episode concludes, Aaron and Erwin hint at a multi-part series on conflict resolution, diving deeper into identifying destructive behaviors, navigating difficult situations, and fostering peace. They invite listeners to join the Mind Shiftcommunity for exclusive content and discussions, encouraging engagement with these vital leadership and personal growth lessons.

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?   Valérie Greffoz, Epsiloon : La glace noire Mathieu Nowak, Sciences et Avenir : L'Everest Guillaume Langin, Ciel & Espace : Où irons-nous vivre ? Elsa Couderc, The Conversation :Jusqu'où Einstein avait-il raison ?  François Lassagne, Pour la Science : Les nouveaux mondes de l'ARN.Musiques diffusées- Public Service Broadcasting – Everest- Beach House - Space Song- Goodie Mob, Outcast - Black Ice (Sky High)- I Monster – Cells- Piers Faccini, Ballaké Sissoko - If Nothing Is Real [Playlist RFI].

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?   Valérie Greffoz, Epsiloon : La glace noire Mathieu Nowak, Sciences et Avenir : L'Everest Guillaume Langin, Ciel & Espace : Où irons-nous vivre ? Elsa Couderc, The Conversation :Jusqu'où Einstein avait-il raison ?  François Lassagne, Pour la Science : Les nouveaux mondes de l'ARN.Musiques diffusées- Public Service Broadcasting – Everest- Beach House - Space Song- Goodie Mob, Outcast - Black Ice (Sky High)- I Monster – Cells- Piers Faccini, Ballaké Sissoko - If Nothing Is Real [Playlist RFI].

Prof Martin Hutchings from Copenhagen University Hospital in Denmark, Dr Manali Kamdar from the University of Colorado Cancer Center, Dr Matthew Lunning from the University of Nebraska Medical Center and Prof Gilles Salles from Memorial Sloan Kettering Cancer Center in New York summarize currently available data guiding treatment decision-making for patients with relapsed/refractory diffuse large B-cell lymphoma and present cases from their practices.CME information and select publications here.

Featuring slide presentations and related discussion from Prof Martin Hutchings, Dr Manali Kamdar, Dr Matthew Lunning and Prof Gilles Salles, including the following topics: Evolving Role of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Kamdar (0:00) Case: A 61-year-old man with Stage IV non-GCB DLBCL receives R-CHOP but experiences disease progression 8 months later (30:39) Case: A 68-year-old man with double-hit DLBCL who experiences disease progression on chemotherapy and second-line CAR T-cell therapy receives glofitamab (39:22) Incorporation of Bispecific Antibody Therapy into DLBCL Management — Prof Hutchings (45:25) Case: A 42-year-old man with progressive DLBCL refractory to 2 lines of therapy receives glofitamab with a durable response (1:07:30) Case: An 81-year-old woman with multiregimen-refractory DLBCL experiences a prolonged response to epcoritamab (1:14:25) Case: A 69-year-old man with follicular lymphoma transformed to DLBCL and refractory to 3 lines of treatment receives glofitamab (1:21:48) Selection and Sequencing of Other Available Therapies for Relapsed/Refractory (R/R) DLBCL — Prof Salles (1:24:37) Case: An 82-year-old woman with follicular lymphoma transformed to DLBCL receives tafasitamab/lenalidomide (1:42:05) Case: A 69-year-old man with urinary bladder carcinoma and recurrent GCB DLBCL receives loncastuximab tesirine (1:46:26) Promising Investigational Approaches for Patients with R/R DLBCL — Dr Lunning (2:00:37) Case: An 80-year-old woman with multiregimen-refractory GCB DLBCL seeks treatment requiring minimal clinic visits and receives loncastuximab tesirine (2:15:59) Case: A 54-year-old man with primary refractory non-GCB DLBCL receives CAR T-cell therapy, and follow-up imaging on day 29 demonstrates a Deauville score of 4 (2:25:22) CME information and select publications

Prof Martin Hutchings from Copenhagen University Hospital in Denmark, Dr Manali Kamdar from the University of Colorado Cancer Center, Dr Matthew Lunning from the University of Nebraska Medical Center and Prof Gilles Salles from Memorial Sloan Kettering Cancer Center in New York summarize currently available data guiding treatment decision-making for patients with relapsed/refractory diffuse large B-cell lymphoma and present cases from their practices.CME information and select publications here.

durée : 00:32:01 - Les Nuits de France Culture - par : Philippe Garbit - Dans l'émission "Collège des ondes - Nouvelles étrangères" consacrée à l'écrivain indien Rabindranath Tagore, Alain Bosquet et Harold Portnoy analysaient l'œuvre du Prix Noel 1913, avec une lecture d'un extrait de son roman "Le Naufrage". - réalisation : Virginie Mourthé

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?   Vincent Nouyrigat, Epsiloon : Le singulier destin des perroquets  Mathieu Nowak, Sciences et Avenir : Les pouvoirs de la respiration  Philippe Henarejos, Ciel & Espace : Dans le temple des fusées lunaires Elsa Couderc, The Conversation : Les « pingers » et autres avertisseurs sonores peuvent-ils aider à réduire le risque de collision entre bateaux et cétacés ? François Lassagne, Pour la Science : L'histoire de la domestication du cheval revisitée.  Musiques diffusées :  La Tordue – Lune Arthur H – Cheval de feu Alexis Harte – Parrots Patrick Watson, November Ultra – Silencio [Playlist RFI] Pinegrove – Respirate    

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?   Vincent Nouyrigat, Epsiloon : Le singulier destin des perroquets  Mathieu Nowak, Sciences et Avenir : Les pouvoirs de la respiration  Philippe Henarejos, Ciel & Espace : Dans le temple des fusées lunaires Elsa Couderc, The Conversation : Les « pingers » et autres avertisseurs sonores peuvent-ils aider à réduire le risque de collision entre bateaux et cétacés ? François Lassagne, Pour la Science : L'histoire de la domestication du cheval revisitée.  Musiques diffusées :  La Tordue – Lune Arthur H – Cheval de feu Alexis Harte – Parrots Patrick Watson, November Ultra – Silencio [Playlist RFI] Pinegrove – Respirate    

Pascal Praud revient sur les propos controversés d'Aurélie Didier, directrice éditoriale adjointe de l'information à la RTBF (Radio-Télévision Belge Francophone). Celle-ci a expliqué que la chaîne diffuserait le discours de l'ancien président américain Donald Trump avec un léger différé, afin de le "décrypter" et d'éviter de "banaliser des propos d'extrême droite". Cette décision soulève de vives critiques de la part de Pascal Praud, qui y voit une forme de censure et de contrôle de la parole. Le débat s'étend également à la situation en Belgique, où certains médias seraient accusés de ne pas couvrir certains événements impliquant l'extrême gauche. Notre équipe a utilisé un outil d'Intelligence artificielle via les technologies d'Audiomeans© pour accompagner la création de ce contenu écrit.Vous voulez réagir ? Appelez-le 01.80.20.39.21 (numéro non surtaxé) ou rendez-vous sur les réseaux sociaux d'Europe 1 pour livrer votre opinion et débattre sur grandes thématiques développées dans l'émission du jour.

The world is chaotic. Systems are failing, towns are burning. If you need to make an appointment with your doctor you may have to wait til July. So it's time to make a show about it all. I implore you to record moments of your day and send me the audio and I will try to make a show that sounds like RIGHT NOW. Email the recordings to me at rumblestripvermont@gmail.com. 

TSN Maple Leafs Reporter, Mark Masters joins Game Play on Craig Berube's ability to diffuse drama, Steven Lorentz's cameo on the first line, if there's any concern for Nylander amid slump.

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec Fiorenza Gracci, Epsiloon : Le miracle de la vie Philippe Pajot, La Recherche : Les sols, un écosystème vital et complexe  Philippe Henarejos, Ciel & Espace : Une mission folle pour explorer Uranus Benoit Tonson, The Conversation : Une nouvelle théorie explique comment l'eau est arrivée sur Terre François Lassagne, Pour la Science : Chromosomes X & Y : pourquoi femmes et hommes ne sont pas égaux face aux maladies  

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ? Avec Fiorenza Gracci, Epsiloon : Le miracle de la vie Philippe Pajot, La Recherche : Les sols, un écosystème vital et complexe  Philippe Henarejos, Ciel & Espace : Une mission folle pour explorer Uranus Benoit Tonson, The Conversation : Une nouvelle théorie explique comment l'eau est arrivée sur Terre François Lassagne, Pour la Science : Chromosomes X & Y : pourquoi femmes et hommes ne sont pas égaux face aux maladies  

Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin… The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with LLS.

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?  Avec Jean-Baptiste Veyrieras, Epsiloon : La découverte de l'oubli Fabrice Nicot, Sciences et Avenir : Voie lactée, révélations sur les mystères de notre galaxie Guillaume Langin, Ciel et Espace : Wotan, l'ingénieur allemand et les dictateurs Elsa Couderc, The Conversation : Comment faire face à la crise de l'énergie de l'intelligence artificielle Thomas Delozier, Science et Vie : À la recherche du 120ème élément François Lassagne, Pour la Science : Objectif Lune – Les enjeux d'un retour annoncé. 

Quelles recherches, quelles découvertes ont retenu l'attention de nos consœurs et confrères de la presse scientifique ce mois-ci ?  Avec Jean-Baptiste Veyrieras, Epsiloon : La découverte de l'oubli Fabrice Nicot, Sciences et Avenir : Voie lactée, révélations sur les mystères de notre galaxie Guillaume Langin, Ciel et Espace : Wotan, l'ingénieur allemand et les dictateurs Elsa Couderc, The Conversation : Comment faire face à la crise de l'énergie de l'intelligence artificielle Thomas Delozier, Science et Vie : À la recherche du 120ème élément François Lassagne, Pour la Science : Objectif Lune – Les enjeux d'un retour annoncé. 

We have a lot going on this week, and it's going to be a serious ride of "let me mind my business." Diffuse any situations at the end of the week, and at the beginning of the week- we have some serious endings, and new beginnings. Let yourself take it a day at a time if needed, and plan accordingly. Rest is essential at this time as well, so take care of yourself out there. This week's notes: November 28-30 moon in scorpio.Balsamic moon, grounding the new moon in scorpio from November 1 st.First moon cycle in several years that we have a new moon in scorpio not connected to the eclipse lunar nodes- lots of big changes are grounding because of this. We're about to come out of the underworld November 30- December 2 moon in sagittarius NEW MOON on December 1- 6:21 am UTCAnything bound up/activated on this new moon, we're bound to come back to it- due to the mercury rx in sagitarrius and the Jupiter rx in gemini Dec 2-4 Moon in CapricornWith VenusDetailed weavings. Reserve your energy, and be very intentional with how you're spending your time, and offering time to others during these days December 5-6 moon in AquariusWith PlutoOur first moon wave with Pluto in Aquarius for this final placement over 18 or so yearsListen to the intuitive messages and respond to the chaos*your response to the chaos is what is binding your fates while Pluto is in Aquarius* December 5-Mercury Rx cazimi/conjunct the sun in sagittariusIllumination on SO MUCH about our Sagittarius energy-Aims, goals, claims, games December 6-Mars Rx starts in LeoRetreat into yourself, and watch how others treat you during this time Other Current Offerings:

Life is full and stressful but even a few seconds of mindfulness or gratitude can help us reset and reenergize, says Denise Pyles, the author of Burn Without Burning Out. Pyles, a former nun who now works in corporate America, explains how we can integrate micro-practices into our daily lives to feel better no matter what is going on around us. For more about Denise Pyles and her book, Burn Without Burning Out go to https://denisepyles.com For more ways to live well, do good, and be happy join our free Simply Said community at https://pollycampbell.substack.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Two religious leaders in Brooklyn became concerned about rising tensions between Black and Jewish residents, and try to launch a new effort to create more understanding between the two communities. But that experiment proved more difficult than they imagined. The new documentary "All God's Children" follows Rabbi Rachel Timoner and Reverend Dr. Robert Waterman, and celebrates its world premiere as part of DOC NYC. We speak with the Rabbi and Reverend, along with director Ondi Timoner. This segment is guest-hosted by Tiffany Hanssen.

As a sensitive or deep feeling person, your nervous system is more reactive. This matters. Because, importantly, your nervous system is the foundation of not just your emotional well-being, but also your relationships well-being— or it's lack of well-being! A chronically overstimulated, stressed out nervous system (which, let's face it, most of us have in our modern world, especially as HSPs) is a loving relationship's biggest enemy.And, so long as your nervous system stays that way, you're going to have a much harder time in your relationship in every way. You'll be like a garden without nourished soil: wilting, fruitless, fried, fragile, and dried out.Listen in to this bonus episode where I announce a very special opportunity for you to break free of reactivity in life and love at the most foundational level, and build a solid foundation of emotional well-being (that grounded safety and nourishing supportiveness that are the very roots of a deeply loving marriage), so you can:Diffuse an argument before it even starts, while keeping your wits and feeling grounded.​Stop irritability, feeling easily triggered, overstimulation, and bouts of stress and anxiety, and live with a daily sense of security, peace and even lightheartedness. ​Stay connected to that big heart of yours when challenges come up between you and your spouse, instead of turning against each other, so you can navigate them with ease and a true sense of collaboration​.Always be able to move into the best state of mind to communicate better than ever before, so you can actually get through to your partner in the ways you've always wanted to (but haven't been able to so far) and finally feel truly heardand feel deeper connection, love, and attraction to your partner–and even have more lightness and fun together!And more… Listen in to learn more about how to build the best foundation for a great relationship to grow from. SHOW NOTES:Learn all about Foundations of Emotional Well-Being Course; The Root Of A Better Relationship  here. And join here. ENJOYING THE SHOW?Don't miss an episode! Subscribe via Apple Podcasts, Spotify, or Stitcher. Leave  a review in Apple Podcasts--we are SO grateful!Get the Podcast Map by becoming a Podcast Supporter, so you can quickly identify the episodes most helpful for your unique relationship, by supporting the podcast (for as little as $3) HERE.

In today's episode, where we're diving into The Secret to Resolving Conflict with renowned conflict resolution expert, Hesha Abrams. Hesha is an internationally acclaimed attorney and mediator, known for her success in resolving high-profile cases with some of the world's biggest companies, including Google, Amazon, Facebook, and Pepsi. She's also the author of the popular new book Holding the Calm: The Secret to Resolving Conflict and Defusing Tension. Hesha is going to share some practical, easy-to-use techniques to defuse tension and resolve conflict—not just with our teens, but with anyone.   Key Takeaways ➡️ Parenting is the hardest job, requiring grace and patience. ➡️ Conflict often stems from power dynamics; understanding this is key. ➡️ Teaching children to handle big feelings is essential. ➡️ Practical techniques can help diffuse tension in conflicts. ➡️ Validation is a powerful tool in conflict resolution. ➡️ Offering a 'do-over' can help repair interactions. ➡️ Modeling good behavior is crucial for teaching children. ➡️ Compassion and understanding are vital in parenting. ➡️ Redirecting destructive behavior requires early intervention. ➡️ It's important to acknowledge that perfection is unattainable in parenting    Connect with Hesha Website: www.holdingthecalm.com Facebook: @HeshaAbramsHoldingTheCalm Instagram: @holdingthecalmbook   Resources Mentioned in This Episode FREE QUIZ: Are You on the RIGHT Track With Your Teen? BOOK: Holding the Calm: The Secret to Resolving Conflict and Defusing Tension     ABOUT THE SHOW: The 'Parenting Teens with Dr. Cam' Podcast: Your Guide to Navigating Adolescence Without the Drama. Hosted by Cameron (Dr. Cam) Caswell, an adolescent psychologist specializing in empowering parents and nurturing teen development. In each episode, she partners with a guest expert to deliver invaluable insights and practical advice for building a closer relationship with your teen & finding joy amidst the challenges Whether you're an experienced parent looking to enhance your teenager's mental well-being and strengthen your connection, or a newcomer to the world of adolescence, this podcast is a must-listen.    #ParentingTeens  #Podcast #teenagers #parentingpodcast #TeenMentalHealth   #MentalHealthAwareness #drcamcaswell #theteentranslator   Connect with Dr. Cam Website:  AskDrCam.com Instagram: @DrCamCaswell Tik Tok: @the.teen.translator

Du gehst in ein Möbelhaus und möchtest im Bäderbereich nach einem Waschtisch schauen. Im Eingang kommt der erste Verkäufer auf dich zu: "Hast du schon unsere Teppiche gesehen?" - Nein, Danke ich suche einen Waschtisch. Plötzlich steht der nächste Verkäufer bei dir: "Hast du schon unsere Dekoartikel gesehen? Heute im Sale" - Nein, Danke ich suche einen Waschtisch Plötzlich ist da Verkäufer Nummer drei: "Heute im Bistro - Oktoberfest" - ICH SUCHE EINEN WASCHTISCH. Und bevor du zum Aufzug gehst, steht da Plötzlich wieder Verkäufer Nummer 1 und bietet dir die Teppiche an... Im normalen Alltag würden wir schreiend wegrennen - im Web sind wir da voll dabei. Viele Unternehmen kommunizieren im Marketing diverse Botschaften, die Leute nur verwirren. In der Podcastfolge erläutert Matthias Niggehoff, was für Fehler dabei entstehen und wie du die Botschaften verkaufsstark schärfst.

Featuring perspectives from Dr Christopher Flowers, Prof Grzegorz S Nowakowski and Dr Laurie H Sehn, moderated by Dr Flowers, including the following topics: Introduction (0:00) Front-Line Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Sehn (1:56) Case: A woman in her late 40s with epidural DLBCL and a compression fracture (Dr Flowers) (12:45) Case: A woman in her late teens with primary intestinal large B-cell lymphoma (Dr Nowakowski)(16:51) Integration of Novel Agents into the Care of Patients with Relapsed/Refractory DLBCL — Dr Flowers (21:14) Case: A man in his late 70s diagnosed with DLBCL with recurrent disease (Dr Nowakowski) (29:38) Case: A woman in her mid 70s with multiple comorbidities diagnosed with DLBCL (Dr Sehn) (36:17) Bispecific Antibody Therapy for DLBCL — Dr Nowakowski (39:39) Case: A man in his late 50s with no comorbidities with recurrent DLBCL (Dr Sehn) (50:50) Case: A patient in their mid 50s with DLBCL who experiences disease relapse after R-CHOP and CAR-T therapies (Dr Flowers) (54:34) CME information and select publications

The Running Channel Meets is where we talk to real runners with incredible stories. Each episode we speak with people who inspire us to run, and give our guests an opportunity to tell their stories, often for the first time.In this episode we chat with Heather Hartley, an Army veteran who served in the British Armed forces as a bomb disposal expert. After two decades of service, including deployments to Iraq and Afghanistan, Heather faced the challenge of severe PTSD. As a single parent navigating life after the military, she had a pivotal moment on Remembrance Day when she laced up an old pair of running shoes and went for her first run in years. Life started to kick in again. Today, Heather embraces a renewed sense of purpose through running, having completed both full and ultra-marathons, with many more challenges on the horizon.Topics that we discuss in this episode:Post Traumatic Stress Disorder.Military and bomb disposal experiences.The Running Channel Meets was born from The Running Channel podcast. Hosted by Sarah Hartley (amateur runner) and Andy Baddeley (former pro runner) alongside Rick Kelsey (recovering runner), the TRC Podcast is friendly, jargon-free, and the perfect accompaniment to your runs.For all enquiries contact podcast@therunningchannel.com .If you liked this, please subscribe wherever you get your podcasts. And leave us a 5* review and rating, it really helps us get discovered.We're on YouTube too, so check us out there: www.youtube.com/runningchannel .

Reasoning with the unreasonable can feel impossible, but here are some techniques to diffuse intense arguments and encourage others to challenge their own cognitive dissonance with curiosity and care. For starters, it's important to find common values to come back to, use metaphors and anecdotes to break down complex ideas and humanize them, remember it's you vs. the problem (not you vs. them), and remember that you're attempting to better understand each other - rather than change each other. RESOURCE 1: https://tinybuddha.com/blog/when-you-strongly-disagree-with-someone-how-to-find-common-ground/RESOURCE 2: https://www.betterup.com/blog/finding-common-ground-with-anyone-a-quick-and-easy-guideYOUTUBE VID BONUS: REASONING WITH UNREASONABLE PEOPLE: https://www.youtube.com/watch?v=VFWF_VnlFAgDONATE:www.pcrf.netGet Involved:Operation Olive Branch: Spreadsheets + LinksGET AN OCCASIONAL PERSONAL EMAIL FROM ME: www.makeyourdamnbedpodcast.comTUNE IN ON INSTAGRAM FOR COOL CONTENT: www.instagram.com/mydbpodcastOR BE A REAL GEM + TUNE IN ON PATREON: www.patreon.com/MYDBpodcastOR WATCH ON YOUTUBE: www.youtube.com/juliemerica The opinions expressed by Julie Merica and Make Your Damn Bed Podcast are intended for entertainment purposes only. Make Your Damn Bed podcast is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Get bonus content on PatreonSupport this show http://supporter.acast.com/make-your-damn-bed. Hosted on Acast. See acast.com/privacy for more information.

Whether you like it or not, you probably have a ticking tax time bomb that will wreak havoc on your finances if you don't take the time to diffuse it. We discuss with IRA expert, Ed Slott, how to keep more of your money now and leave more for your heirs. His new book is The Retirement Savings Time Bomb Ticks Louder: How to Avoid Unnecessary Tax Landmines, Defuse the Latest Threats to Your Retirement Savings, and Ignite Your Financial Freedom Learn more about your ad choices. Visit megaphone.fm/adchoices